Cardiac arrhythmia is one of the leading causes of death in industrial nations. It also causes an increased risk of stroke. Many forms of cardiac arrhythmia can be treated gently with minimally invasive procedures using radiofrequency ablation. In this treatment procedure, a catheter is inserted into the heart to locate the tissue responsible for the arrhythmia. The tissue is then targeted or isolated using radiofrequency current to stop the arrhythmia.
The G4 platform from Stockert is the market-leading solution for cardiac radiofrequency ablation in electrophysiology.
Components and accessories
 Chugh, S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E., Gillum, R., Kim, Y., McAnulty, J., Zheng, Z., Forouzanfar, M., Naghavi, M., Mensah, G., Ezzati, M. and Murray, C., 2014. Worldwide Epidemiology of Atrial Fibrillation. Circulation, 129(8), pp.837-847.
 Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple Cause of Death 1999-2019 on CDC WONDER Online Database, released in 2020. Data are from the Multiple Cause of Death Files, 1999-2019, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Accessed at http://wonder.cdc.gov/mcd-icd10.html on Nov 25, 2021